5 results match your criteria: "Xianyang First People's Hospital No. 10[Affiliation]"
Clinical value of prognostic nutritional index combined with C-reactive protein and albumin in early prediction of anastomotic leakage after radical gastric cancer surgery.
Am J Transl Res
July 2024
Department of Gastroenterology, Xianyang First People's Hospital No. 10 Biyuan Road, Qindu District, Xianyang 712000, Shaanxi, China.
Objective: To evaluate the predictive value of the Prognostic Nutritional Index (PNI) combined with C-reactive protein (CRP) and albumin (ALB) for anastomotic leakage following radical gastric cancer surgery.
Methods: A retrospective case-control study was conducted with 275 gastric cancer patients at the Second People's Hospital of Lanzhou City from September 2019 to October 2022. Patients were categorized into an anastomotic leakage group (n=31) or a non-leakage group.
Levosimendan improves cardiac function, hemodynamics, and body inflammation in patients with acute myocardial infarction and heart failure.
Am J Transl Res
September 2023
Cardiovascular Ward I, Xi'an Fifth Hospital No. 112, Xiguanzheng Street, Lianhu District, Xi'an 710000, Shaanxi, China.
Objective: To examine the effects of levosimendan on cardiac function, hemodynamics, and body inflammation of patients with acute myocardial infarction and heart failure.
Methods: A retrospective analysis was conducted on 113 acute myocardial infarction patients with heart failure (admitted to Xianyang First People's Hospital from September 2018 to January 2022). According to the treatment plan, patients were categorized into a control group (n = 53) (treated with conventional diuresis and vasodilation) and observation group (n = 60) (treated with levosimendan in addition to the treatment of the control group).
DC-CIK combined with chemotherapy on the efficacy, immune function, and life quality in colorectal cancer patients after radical resection.
Am J Transl Res
April 2023
Department of Oncology, Yanan University Affiliated Hospital No. 43 North Street, Baota District, Yan'an 716000, Shaanxi, China.
Objective: To investigate the efficacy of combined treatment of dendritic cell-cytokine-induced killer cells (DC-CIK) and chemotherapy on colorectal cancer (CRC) patients who have undergone radical resection, and its effect on immune function and quality of life.
Methods: Data of 103 CRC patients after radical resection admitted to Xianyang First People's Hospital and Yanan University Affiliated Hospital from March 2018 to March 2020 were retrospectively analyzed. A total of 50 patients treated with XELOX chemotherapy were included in the control group (CG).
Prognostic value and risk model construction of hypoxic stress-related features in predicting gastric cancer.
Am J Transl Res
December 2022
Department of Gastroenterology, Xianyang First People's Hospital No. 10, Biyuan Road, Qindu District, Xianyang 712000, Shaanxi, China.
Objective: Hypoxia promotes tumor progression from multiple aspects, including metabolism, proliferation, migration and angiogenesis. Therefore, a thorough understanding of the impact of hypoxia on gastric adenocarcinoma (STAD) is warranted. The aim of the present study was to find a prognostic model of hypoxia in gastric cancer (GC) and its relationship with the immune microenvironment.
View Article and Find Full Text PDFImprovement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Am J Transl Res
August 2022
Otolaryngology, The Affiliated Hospital of Shaanxi University of Chinese Medicine No. 2, Weiyang West Road, Xianyang 712000, Shaanxi Province, China.
Article Synopsis
- This study assessed the impact of combining nimotuzumab with a chemotherapy regimen (Taxol + Cisplatin) and radiotherapy on the treatment outcomes for patients with locally advanced nasopharyngeal carcinoma.
- A retrospective analysis of 91 patients showed that those receiving nimotuzumab had better outcomes, including improved lymph node remission rates and lower levels of specific serum markers, compared to those who did not receive it.
- No significant differences in adverse reactions were found between the two groups, indicating that the combination treatment is not only effective but also safe for patients.